Viome Life Sciences raised $25 million in a Series D round and appointed Kal Raman as the new COO. The company offers total body intelligence tests for personalized food recommendations and supplements, as well as an oral health test. Viome plans to expand its offerings and launch a diagnostic division. With a focus on early detection of diseases, Viome uses AI technology and a large database of gene expression data. The company received FDA breakthrough device designation for its cancer detection technology and has partnered with GlaxoSmithKline for research on chronic diseases. Viome has raised a total of $175 million in funding.
Source link
Viome secures $25M, hires former Amazon, Groupon, Samsung executive
